De Burlo Group’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-31,900	Closed	-$5.46M	–	102
2018 Q3	$5.46M	Buy	31,900 +4,970	+18%	+$851K	1.02%	36
2018 Q2	$3.48M	Buy	+26,930	New	+$3.48M	0.74%	33